ROCHESTER MEDICAL CORPORATION: 10-Q filed 2013-05-10

Name: ROCHESTER MEDICAL CORPORATION: 10-Q filed 2013-05-10
Creator: ROCHESTER MEDICAL CORPORATION

What ROCHESTER MEDICAL CORPORATION reported in its quarterly report filed 2013-05-10 (fiscal Q2 2013): 41 published measures, 110 facts as tagged in accession 0001104659-13-040109.

This filing

Form: 10-Q (quarterly report)
Filed: 2013-05-10
Fiscal period: fiscal Q2 2013
Accession: 0001104659-13-040109 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All ROCHESTER MEDICAL CORPORATION filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2013-03-31	77,516,802	USD
At 2012-09-30	75,930,734	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2013-03-31	70,600,526	USD
At 2012-09-30	68,295,796	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2013-03-31	16,291,745	USD
At 2012-09-30	13,921,363	USD
At 2012-03-31	8,813,309	USD
At 2011-09-30	8,722,935	USD

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2012-10-01 to 2013-03-31	1,849,729	USD	182
2011-10-01 to 2012-03-31	913,199	USD	183

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2013-03-31	17,525,253	USD
At 2012-09-30	15,313,858	USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

Period	Value	Unit	Days
2013-01-01 to 2013-03-31	12,146,969	shares	90
2012-10-01 to 2013-03-31	12,092,003	shares	182
2012-01-01 to 2012-03-31	12,003,167	shares	91
2011-10-01 to 2012-03-31	12,049,900	shares	183

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

Period	Value	Unit	Days
2013-01-01 to 2013-03-31	12,604,099	shares	90
2012-10-01 to 2013-03-31	12,482,558	shares	182
2012-01-01 to 2012-03-31	12,235,701	shares	91
2011-10-01 to 2012-03-31	12,258,402	shares	183

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

Period	Value	Unit	Days
2013-01-01 to 2013-03-31	0.1	USD/shares	90
2012-10-01 to 2013-03-31	0.18	USD/shares	182
2012-01-01 to 2012-03-31	0.05	USD/shares	91
2011-10-01 to 2012-03-31	0.04	USD/shares	183

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

Period	Value	Unit	Days
2013-01-01 to 2013-03-31	0.1	USD/shares	90
2012-10-01 to 2013-03-31	0.18	USD/shares	182
2012-01-01 to 2012-03-31	0.05	USD/shares	91
2011-10-01 to 2012-03-31	0.04	USD/shares	183

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

Period	Value	Unit	Days
2013-01-01 to 2013-03-31	523,892	USD	90
2012-10-01 to 2013-03-31	899,514	USD	182
2012-01-01 to 2012-03-31	281,599	USD	91
2011-10-01 to 2012-03-31	245,147	USD	183

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2013-03-31	12,769,153	USD
At 2012-09-30	11,862,072	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2012-10-01 to 2013-03-31	383,795	USD	182
2011-10-01 to 2012-03-31	563,667	USD	183

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2013-01-01 to 2013-03-31	1,773,223	USD	90
2012-10-01 to 2013-03-31	3,150,727	USD	182
2012-01-01 to 2012-03-31	834,331	USD	91
2011-10-01 to 2012-03-31	813,602	USD	183

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2013-03-31	46,067,253	USD
At 2012-09-30	44,607,223	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2012-10-01 to 2013-03-31	2,358	USD	182
2012-01-01 to 2012-03-31	8,395	USD	91
2011-10-01 to 2012-03-31	89,545	USD	183

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2013-03-31	5,787,635	USD
At 2012-09-30	6,497,726	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2013-03-31	2,252,362	USD
At 2012-09-30	3,070,329	USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

Period	Value	Unit	Days
At 2013-03-31	8,785,417	USD
At 2012-09-30	9,053,091	USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

Period	Value	Unit	Days
At 2013-03-31	8,806,574	USD
At 2012-09-30	9,377,354	USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

Period	Value	Unit	Days
At 2013-03-31	10,776,753	USD
At 2012-09-30	11,008,429	USD

Common-stock repurchase payments

Cash paid to reacquire common stock during the period. This is not an authorization limit or a direct measure of the net change in share count.

Period	Value	Unit	Days
2011-10-01 to 2012-03-31	1,088,619	USD	183

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2013-01-01 to 2013-03-31	6,622,366	USD	90
2012-10-01 to 2013-03-31	13,718,110	USD	182
2012-01-01 to 2012-03-31	6,770,003	USD	91
2011-10-01 to 2012-03-31	13,901,871	USD	183

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

Period	Value	Unit	Days
At 2013-03-31	9,265,672	USD
At 2012-09-30	9,883,651	USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

Period	Value	Unit	Days
2013-01-01 to 2013-03-31	8,395,589	USD	90
2012-10-01 to 2013-03-31	16,868,837	USD	182
2012-01-01 to 2012-03-31	7,604,334	USD	91
2011-10-01 to 2012-03-31	14,715,473	USD	183

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2013-01-01 to 2013-03-31	312,023	USD	90
2012-10-01 to 2013-03-31	651,181	USD	182
2012-01-01 to 2012-03-31	247,889	USD	91
2011-10-01 to 2012-03-31	624,158	USD	183

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2013-03-31	12,327,143	shares
At 2012-09-30	12,120,050	shares

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

Period	Value	Unit	Days
At 2013-03-31	-5,020,820	USD
At 2012-09-30	-3,922,370	USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

Period	Value	Unit	Days
At 2013-03-31	32,924,542	USD
At 2012-09-30	31,202,079	USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

Period	Value	Unit	Days
At 2013-03-31	20,155,389	USD
At 2012-09-30	19,340,007	USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

Period	Value	Unit	Days
At 2013-03-31	8,806,573	USD
At 2012-09-30	9,377,354	USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2013-03-31	2,017,458	USD
At 2012-09-30	1,456,929	USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

Period	Value	Unit	Days
At 2013-03-31	1,905,531	USD
At 2012-09-30	1,726,908	USD

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

Period	Value	Unit	Days
2013-01-01 to 2013-03-31	-429,282	USD	90
2012-10-01 to 2013-03-31	1,111,124	USD	182
2012-01-01 to 2012-03-31	1,596,442	USD	91
2011-10-01 to 2012-03-31	1,052,769	USD	183

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

Period	Value	Unit	Days
2013-01-01 to 2013-03-31	1,199,250	USD	90
2012-10-01 to 2013-03-31	2,211,395	USD	182
2012-01-01 to 2012-03-31	602,514	USD	91
2011-10-01 to 2012-03-31	527,167	USD	183

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2013-01-01 to 2013-03-31	2,148,164	USD	90
2012-10-01 to 2013-03-31	4,355,706	USD	182
2012-01-01 to 2012-03-31	2,128,024	USD	91
2011-10-01 to 2012-03-31	4,236,837	USD	183

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

Period	Value	Unit	Days
2012-10-01 to 2013-03-31	852,673	USD	182
2011-10-01 to 2012-03-31	813,815	USD	183

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

Period	Value	Unit	Days
2013-01-01 to 2013-03-31	-61,131	USD	90
2012-10-01 to 2013-03-31	-57,782	USD	182
2012-01-01 to 2012-03-31	48,712	USD	91
2011-10-01 to 2012-03-31	29,057	USD	183

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

Period	Value	Unit	Days
2012-10-01 to 2013-03-31	-76,228	USD	182
2011-10-01 to 2012-03-31	15,433	USD	183

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2012-10-01 to 2013-03-31	-3,600	USD	182
2011-10-01 to 2012-03-31	1,204,094	USD	183

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

Period	Value	Unit	Days
2012-10-01 to 2013-03-31	-469,498	USD	182
2011-10-01 to 2012-03-31	20,175	USD	183

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

Period	Value	Unit	Days
2012-10-01 to 2013-03-31	-767,485	USD	182
2011-10-01 to 2012-03-31	-398,174	USD	183

Inspect the source

Entity: ROCHESTER MEDICAL CORPORATION / CIK 0000868368
Captured: 2026-09-22 19:32 UTC
SEC response SHA-256: 362e84110d61e12107b2cc1736ab51c9a476834b83d5df8d84105658c207df9f

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000868368.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))